维生素D通路基因CYP27B1与CYP2R1多态性与自身免疫性内分泌疾病的关联:一项Meta分析
该Meta分析纳入14项病例对照研究,共12 929例患者和12 907名健康对照,评估CYP27B1和CYP2R1多态性与自身免疫性内分泌疾病的关联。结果显示CYP27B1 rs10877012次要等位基因A和rs4646536次要等位基因C与总体疾病风险降低相关,而rs10741657无显著关联。
要点
- CYP27B1 rs10877012 A等位基因与自身免疫性内分泌疾病风险降低相关。
- CYP27B1 rs4646536 C等位基因同样显示保护性关联。
- CYP2R1 rs10741657与疾病风险无显著遗传关联。
核心结论
- CYP27B1 rs10877012次要等位基因A和rs4646536次要等位基因C与器官特异性自身免疫性内分泌疾病易感性呈负相关。
研究设计与样本
- Meta分析纳入Pubmed、Embase、Cochrane Library和中国知网数据库中符合入选和质量标准的病例对照研究。
- 共汇总14项研究,包括12 929例患者(2243例自身免疫性Addison病、1253例Graves病、612例桥本甲状腺炎、8821例1型糖尿病)和12 907名健康对照。
- 统计分析使用STATA 16.0软件。
主要发现
- rs10877012次要等位基因A及其纯合子和杂合子降低总体疾病风险:显性模型OR=0.748(95%CI 0.620-0.902),隐性模型OR=0.709(95%CI 0.571-0.879),等位基因模型OR=0.777(95%CI 0.674-0.895)。
- rs4646536次要等位基因C及其纯合子和杂合子降低总体自身免疫性内分泌疾病风险:显性模型OR=0.849(95%CI 0.748-0.963),隐性模型OR=0.868(95%CI 0.790-0.955),等位基因模型OR=0.915(95%CI 0.875-0.957)。
- rs10741657未发现显著遗传关联。
临床怎么用
- 对于自身免疫性内分泌疾病患者,可关注CYP27B1 rs10877012和rs4646536多态性作为潜在风险修饰因素。
- 不建议将CYP2R1 rs10741657多态性常规用于这些疾病的遗传风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Studies on organ-specific autoimmune endocrine disorders showed correlations between disease risks and vitamin D pathways gene variants, such as CYP27B1 rs10877012 and rs4646536, or CYP2R1 rs10741657 single nucleotide polymorphisms. However, previous works presented inconsistent conclusions. Our study aimed at assessing the association of CYP27B1 and CYP2R1 polymorphisms with autoimmune endocrine disorder susceptibility using the meta-analysis method. METHODS: Case-control studies of the subject of interest were identified from the databases Pubmed, Embase, Cochrane Library, and China National Knowledge Infrastructure. Studies that met inclusion and quality criteria were pooled. Observational outcomes were diagnosis of autoimmune Addison's disease, Graves disease, Hashimoto thyroiditis, or type 1 diabetes mellitus. Statistical analysis was performed using software STATA 16.0. RESULTS: A total of 14 studies involving 12 929 patients (2243 autoimmune Addison disease, 1253 Graves disease, 612 Hashimoto thyroiditis, 8821 type 1 diabetes), and 12 907 healthy control subjects were pooled for meta-analysis. The rs10877012 minor allele A and its homozygote and heterozygote conferred low overall disease risk (OR [odds ratio] = 0.748, 95% CI [confidence interval] 0.620-0.902 in dominant model; OR = 0.709, 95% CI 0.571-0.879 in recessive model; OR = 0.777, 95% CI 0.674-0.895 in the allele model). The population carrying rs4646536 minor allele C and its homozygote and heterozygote showed decreased overall autoimmune endocrine disorders risk (OR = 0.849, 95% CI 0.748-0.963; OR = 0.868, 95% CI 0.790-0.955; OR = 0.915, 95% CI 0.875-0.957 in the dominant, recessive, and allele model, respectively). No significant genetic association was found for rs10741657. CONCLUSION: Our study suggested CYP27B1 polymorphisms rs10877012 minor allele A and rs4646536 minor allele C were negatively related to susceptibilities of organ-specific autoimmune endocrine diseases.
引用
- Ma X, Xie Z, Qin J, et al. Association of Vitamin D Pathway Gene CYP27B1 and CYP2R1 Polymorphisms with Autoimmune Endocrine Disorders: A Meta-Analysis. J Clin Endocrinol Metab. 2020. PMID: 32915988. doi:10.1210/clinem/dgaa525
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。